NUGL
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | 0.00 | $866,024 | $25,610 |
| 2025 Q1 | 0.00 | $751,048 | -$8,930 |
| 2024 Q4 | -0.00 | $936,231 | -$61,700 |
| 2024 Q3 | -0.00 | $726,751 | $54,770 |
| 2024 Q2 | 0.00 | $708,596 | -$63,897 |
| 2024 Q1 | 0.00 | $601,608 | $32,884 |
| 2023 Q4 | -0.00 | $646,669 | $34,709 |
| 2023 Q3 | 0.00 | $421,316 | $85,641 |